How I Invest with David Weisburd

Chris Prestigiacomo from SWIB discusses the role of private debt in venture portfolio management, backing criteria for General Partners, venture capital's role in SWIB's strategy, and Wisconsin's retirement system governance. They also explore venture investments, portfolio allocation, investment strategy, governance, and criteria for investment decisions with venture capitalists.

Former child actor Sasha Pieterse, now CEO of Hippie Water, talks about her journey to entrepreneurship, the cannabis beverage market, D2C strategies, and the importance of authentic representation. They also discuss challenges faced by female founders, empowering women in entrepreneurship, and navigating Hollywood as a young celebrity.

Katie Riester, Managing Director at Felicis talks with David Weisburd about venture capital fund strategies, building relationships with GPs, and the math behind venture capital. They discuss clear communication with LPs, common red flags, and advice for new LPs.

Michael Sidgmore of Broadhaven discusses the growth of the wealth channel, access issues for family offices, GP stakes, the future of emerging managers, and the potential of IRA funds for venture capital and real estate investments.

Dave McClure, founder of 500 Startups, discusses his journey into venture capital, his investment strategy, and the challenges of breaking into the industry. He analyzes his two 40x+ funds, talks about the misalignment between LPs and GPs, and explores the concept of his new firm, Practical Venture Capital. They also discuss competition in the secondary market, the trade-off between unrealized TDPI and realized DPI, and the potential opportunities in emerging markets for international expansion.

Investment strategist Guy Perelmuter discusses his investment strategy, the paradox of AI, the potential of DeepTech, and the impact of AI on the labor force. They also touch on LP value-add, the importance of overcommunication, and the ideal GP relationship. They explore the convergence of technology and biology in biotech, OpenAI's plans for an AI app store, and the debate on effective altruism and responsible development of AI. Perelmuter emphasizes the importance of diversification, consistent returns, and leveraging network and partnerships in venture capital.

Carrie Thome & Grady Buchanan of NVNG discuss startups, portfolio construction, strategic investment, and raising a fund during COVID. They also cover talent competition, liquidity management, and assessing emerging manager quality in venture capital.

Errik Anderson, co-founder of 20 biotech startups worth $10B+, discusses the potential of the biotech industry, the value of building relationships, and practicing pro-noia. They explore the challenges and innovation in biotech, the costs of starting a company, and the benefits of collaboration. They also talk about mindset, teamwork, and building strong relationships to create billion-dollar opportunities.

Anubhav Srivastava, CEO of Tactyc, discusses portfolio construction, fund recycling, reserve strategies, and follow-on investments. They also explore the future of Tactyc and lessons from clients.

Ben Gallagher, a venture capital expert, discusses the challenges faced by emerging managers in the industry. They delve into topics such as check sizes, diligence processes, and the impact of a GP leaving during an investment life cycle. The role of CFO/COO in GP operations and the importance of supporting emerging managers are also covered.